JP4227778B2 - アネキシン５の生理活性抑制物質 - Google Patents

アネキシン５の生理活性抑制物質 Download PDF

Info

Publication number
JP4227778B2
JP4227778B2 JP2002243750A JP2002243750A JP4227778B2 JP 4227778 B2 JP4227778 B2 JP 4227778B2 JP 2002243750 A JP2002243750 A JP 2002243750A JP 2002243750 A JP2002243750 A JP 2002243750A JP 4227778 B2 JP4227778 B2 JP 4227778B2
Authority
JP
Japan
Prior art keywords
annexin
physiological activity
polypeptide
sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002243750A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004081038A5 (https=
JP2004081038A (ja
Inventor
光盛 汾陽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
National Institute of Japan Science and Technology Agency
Original Assignee
Japan Science and Technology Agency
National Institute of Japan Science and Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency, National Institute of Japan Science and Technology Agency filed Critical Japan Science and Technology Agency
Priority to JP2002243750A priority Critical patent/JP4227778B2/ja
Priority to PCT/JP2003/010596 priority patent/WO2004018670A1/ja
Publication of JP2004081038A publication Critical patent/JP2004081038A/ja
Publication of JP2004081038A5 publication Critical patent/JP2004081038A5/ja
Application granted granted Critical
Publication of JP4227778B2 publication Critical patent/JP4227778B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2002243750A 2002-08-23 2002-08-23 アネキシン５の生理活性抑制物質 Expired - Fee Related JP4227778B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2002243750A JP4227778B2 (ja) 2002-08-23 2002-08-23 アネキシン５の生理活性抑制物質
PCT/JP2003/010596 WO2004018670A1 (ja) 2002-08-23 2003-08-21 アネキシン５の生理活性抑制物質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002243750A JP4227778B2 (ja) 2002-08-23 2002-08-23 アネキシン５の生理活性抑制物質

Publications (3)

Publication Number Publication Date
JP2004081038A JP2004081038A (ja) 2004-03-18
JP2004081038A5 JP2004081038A5 (https=) 2004-10-14
JP4227778B2 true JP4227778B2 (ja) 2009-02-18

Family

ID=31944105

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002243750A Expired - Fee Related JP4227778B2 (ja) 2002-08-23 2002-08-23 アネキシン５の生理活性抑制物質

Country Status (2)

Country Link
JP (1) JP4227778B2 (https=)
WO (1) WO2004018670A1 (https=)

Also Published As

Publication number Publication date
WO2004018670A1 (ja) 2004-03-04
JP2004081038A (ja) 2004-03-18

Similar Documents

Publication Publication Date Title
US7790683B2 (en) Leptin-related peptides
Adams et al. Three forms of gonadotropin-releasing hormone, including a novel form, in a basal salmonid, Coregonus clupeaformis
US20040043932A1 (en) Leptin-related peptides
JP2004512011A (ja) 非哺乳類ＧｎＲＨ類似体および腫瘍細胞成長調節および癌治療におけるその使用
KR20100099249A (ko) 세포막 재봉합을 조절하기 위한 조성물 및 방법
JP2000512134A (ja) Ｊａｇｇｅｄ／Ｎｏｔｃｈタンパク質および核酸に基づく治療および診断の方法および組成物
WO2000024890A1 (en) Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
Siler-Khodr et al. Action of chicken II GnRH on the human placenta
JPH10229887A (ja) 神経ペプチドレセプターｈｆｇａｎ７２の新規なリガンド
KR20160118264A (ko) 스테로이드제 투여로 유발되는 성장 장해에 대한 의약
Trudeau et al. Is secretoneurin a new hormone?
Malendowicz et al. Neuromedins U and S involvement in the regulation of the hypothalamo–pituitary–adrenal axis
Kochman Evolution of gonadotropin-releasing hormone (GnRH) structure and its receptor
JP2002515444A (ja) 骨粗鬆症の治療方法
Li et al. Topical GDF11 accelerates skin wound healing in both type 1 and 2 diabetic mouse models
Friry et al. Production of recombinant large proneurotensin/neuromedin N-derived peptides and characterization of their binding and biological activity
EP2497780A1 (en) TDF-related compounds and analogs thereof
Nie et al. Molecular cloning, immunological characterization, and expression analysis of gonadotropin-releasing hormone (GnRH) in the brain of the Chinese alligator during different stages of reproductive cycle
Asami et al. Physicochemically and pharmacokinetically stable nonapeptide KISS1 receptor agonists with highly potent testosterone-suppressive activity
US8088889B2 (en) Teneurin c-terminal associated peptides (TCAP) and uses thereof
JP4227778B2 (ja) アネキシン５の生理活性抑制物質
EP4446335A1 (en) Novel peptide and use thereof
KR20010043088A (ko) 신규인 폴리펩티드, 그 폴리펩티드를 코드화하는 ｃＤＮＡ및 그 용도
US6664229B2 (en) Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
US10925933B2 (en) Method of preventing rheumatoid arthritis comprising administering polynucleotide encoding SSU72

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20040129

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040721

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070109

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070312

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080904

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081029

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20081125

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20081201

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111205

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121205

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees